Loading clinical trials...
Loading clinical trials...
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Conditions
Interventions
Aducanumab (BIIB037)
Aducanumab (BIIB037)
+1 more
Locations
181
United States
St. Joseph's Hospital and Medical Center
Phoenix, Arizona, United States
Center for Neurosciences
Tucson, Arizona, United States
Neurology Center of North Orange County
Fullerton, California, United States
Senior Clinical Trials, Inc.
Laguna Hills, California, United States
Torrance Clinical Research Institute, Inc.
Lomita, California, United States
University of California - Los Angeles
Los Angeles, California, United States
Start Date
August 13, 2015
Primary Completion Date
August 8, 2019
Completion Date
August 8, 2019
Last Updated
September 2, 2021
NCT06159673
NCT07457138
NCT07033494
NCT07214727
NCT07422857
NCT06584357
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions